BlackRock’s Ocera Therapeutics, Inc. OCRX Stock Holding History

BlackRock’s Portfolio OCRX Stock Details OCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-74,716	Closed	-$86K	–	5063
2017 Q3	$86K	Sell	74,716 -1,085	-1%	-$1.16K	﹤0.01%	4389
2017 Q2	$88K	Buy	75,801 +13,427	+22%	+$15.6K	﹤0.01%	4427
2017 Q1	$82K	Buy	+62,374	New	+$79.4K	﹤0.01%	4370

BlackRock's OCRX Position: Q4 2017 in Review

BlackRock sold out of Ocera Therapeutics, Inc. (OCRX) in Q4 2017, closing a stake of 74,716 shares — an estimated $86K sold.

BlackRock first reported a position in OCRX in Q1 2017 and held it in 3 quarters. The position peaked at $88K in Q2 2017. 0 funds tracked by Wall St. Rank hold OCRX as of Q4 2017.

BlackRock reported no remaining Ocera Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
BlackRock sold 74,716 Ocera Therapeutics, Inc. shares in Q4 2017, an estimated $86K.
BlackRock first reported a position in Ocera Therapeutics, Inc. in Q1 2017 and held it in 3 quarters.
BlackRock's Ocera Therapeutics, Inc. position peaked at $88K in Q2 2017.
0 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q4 2017.

Based on BlackRock's 13F filing for Q4 2017, filed 9 Feb 2018.